- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/78 - Hydrolases (3.) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Patent holdings for IPC class C12N 9/78
Total number of patents in this class: 1425
10-year publication summary
27
|
49
|
54
|
71
|
85
|
121
|
159
|
148
|
170
|
127
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Beam Therapeutics Inc. | 242 |
95 |
President and Fellows of Harvard College | 5995 |
92 |
The Broad Institute, Inc. | 1837 |
84 |
Massachusetts Institute of Technology | 10102 |
43 |
The Regents of the University of California | 20059 |
31 |
National University Corporation Kobe University | 531 |
22 |
The General Hospital Corporation | 4759 |
20 |
Spogen Biotech Inc. | 137 |
18 |
Zhejiang University of Technology | 259 |
16 |
Lifeedit Therapeutics, Inc. | 58 |
14 |
PureTech Scientific LLC | 35 |
14 |
BASF SE | 20979 |
13 |
DSM IP Assets B.V. | 5581 |
13 |
Illumina, Inc. | 3372 |
12 |
The Trustees of the University of Pennsylvania | 4337 |
11 |
Amano Enzyme Inc. | 398 |
11 |
Pairwise Plants Services, Inc. | 246 |
11 |
Pioneer Hi-Bred International, Inc. | 6627 |
10 |
CJ Cheiljedang Corporation | 3441 |
10 |
Polaris Group | 20 |
10 |
Other owners | 875 |